Skip to content
Nystatin
Barstatin, Candex, Korostatin, Myco-triacet, Mycolog-ii, Mycostatin, Mykinac, Mytrex F, Nilstat, Nysert, Nystaform, Nystex (nystatin) is a small molecule pharmaceutical. Nystatin was first approved as Nystaform on 1982-01-01. It is used to treat chronic mucocutaneous candidiasis, cutaneous candidiasis, mycoses, oral candidiasis, and vulvovaginal candidiasis in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
stomatognathic diseasesD009057
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Clioquinol
+
Nystatin
Tradename
Company
Number
Date
Products
NYSTAFORMBayerN-050235 DISCN1982-01-01
1 products
Hide discontinued
Nystatin
Tradename
Company
Number
Date
Products
CANDEXBayerN-050233 DISCN1982-01-01
1 products
NILSTATChartwell PharmaceuticalsN-050299 DISCN1982-01-01
1 products, RLD
MYCOSTATINDelcor AssetN-050619 DISCN1987-04-09
1 products
NILSTATStrides Pharma GlobalN-050576 DISCN1983-12-22
1 products, RLD
NYSERTWarner ChilcottN-050478 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
mycostatinANDA2023-01-05
nystatinANDA2023-06-07
nystopANDA2022-02-09
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
chronic mucocutaneous candidiasisOrphanet_1334D002178B37.2
cutaneous candidiasisD002179
mycosesD009181B35-B49
oral candidiasisEFO_0007406D002180B37.0
vulvovaginal candidiasisEFO_0007543D002181B37.3
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents
A07A: Intestinal antiinfectives
A07AA: Antibiotics, intestinal
A07AA02: Nystatin
D: Dermatologicals
D01: Antifungals for dermatological use
D01A: Antifungals for topical use
D01AA: Antifungal antibiotics, topical
D01AA01: Nystatin
G: Genito urinary system and sex hormones
G01: Gynecological antiinfectives and antiseptics
G01A: Antiinfectives and antiseptics, excl. combinations with corticosteroids
G01AA: Antibiotics, gynecological
G01AA01: Nystatin
G01AA51: Nystatin, combinations
HCPCS
No data
Clinical
Clinical Trials
106 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
EndometriosisD004715EFO_0001065N80391215
Healthy volunteers/patients14115
LeiomyomaD007889HP_0000131D2527110
MenorrhagiaD008595N92.06219
ContraceptionD0032671326
MenopauseD008593EFO_0003922N9521216
Pelvic painD0176992215
MetrorrhagiaD008796HP_0100608N92.1134
DysmenorrheaD004412HP_0100607N94.6314
HivD006678O98.7112
Show 8 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Systemic lupus erythematosusD008180EFO_0002690M321113
Rheumatoid arthritisD001172EFO_0000685M06.9112
Contraception behaviorD003268112
LymphomaD008223C85.9111
Fertility preservationD059247111
OvulationD01006011
PostmenopauseD01769811
Hot flashesD01958411
Breast neoplasmsD001943EFO_0003869C5011
DyspareuniaD004414HP_0030016N94.111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Endometrial hyperplasiaD004714N85.0213
PregnancyD011247EFO_0002950Z33.1112
Hiv infectionsD015658EFO_0000764B2011
Endometrial neoplasmsD016889EFO_000423011
Polycystic ovary syndromeD011085EFO_0000660E28.211
HyperandrogenismD01758811
Relapsing-remitting multiple sclerosisD020529EFO_000392911
Chronic progressive multiple sclerosisD02052811
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8022
Type 2 diabetes mellitusD003924EFO_0001360E1122
PharmacokineticsD01059911
Biological availabilityD00168211
Psoriatic arthritisD015535EFO_0003778L40.511
PsoriasisD011565EFO_0000676L4011
Inflammatory bowel diseasesD015212EFO_000376711
InfectionsD007239EFO_000054411
Ovarian neoplasmsD010051EFO_0003893C5611
Hepatitis cD006526B19.211
Show 2 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acquired immunodeficiency syndromeD000163EFO_0000765B2011
Blood coagulation disordersD001778EFO_0009314D68.911
HeadacheD006261HP_0002315R5111
Appetitive behaviorD00107011
Pregnancy rateD01887311
Pregnancy complicationsD01124811
High-risk pregnancyD01856611
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNYSTATIN
INNnystatin
Description
Nystatin, sold under the brandname Mycostatin among others, is an antifungal medication. It is used to treat Candida infections of the skin including diaper rash, thrush, esophageal candidiasis, and vaginal yeast infections. It may also be used to prevent candidiasis in those who are at high risk. Nystatin may be used by mouth, in the vagina, or applied to the skin.
Classification
Small molecule
Drug classenzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2
Identifiers
PDB
CAS-ID1400-61-9
RxCUI7597
ChEMBL IDCHEMBL450895
ChEBI ID
PubChem CID14960
DrugBankDB00646
UNII IDBDF1O1C72E (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 14,491 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
14,034 adverse events reported
View more details